Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Novel Approach of Combined Lithium-Ketamine Therapy in Bipolar Depression: To Preserve Efficacy and Minimize Adverse Effects


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01768767

Organisation Name: Yale University

Overal Status: Withdrawn

Start Date: January 2013

Last Update: March 9, 2020

Lead Sponsor: Yale University

Brief Summary: This study is looking at the safety and efficacy of combined ketamine and lithium therapy for treating patients with bipolar depression who are taking a mood stabilizer that is not working for them.

Conditions:
  • Bipolar Depression


Total execution time in seconds: 0.20482897758484